BofA Securities Reiterates Buy Rating on Werewolf Therapeutics Inc. (HOWL)
Tweet Send to a Friend
BofA Securities analyst Jason Zemansky reiterated a Buy rating and $10.00 price target on Werewolf Therapeutics Inc. (NASDAQ: HOWL).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


